Report Interpretation

Overview

This report reassesses China Merchants Securities' A- and H-share upside ahead of 3Q26 results. J.P. Morgan's central view is that CMS has unusually high exposure to ChangXin Memory Technologies (CXMT), allowing investment gains to offset pressure on brokerage activity and create a near-term earnings catalyst.

Core views

J.P. Morgan argues that CMS stands out among China brokers because of its exposure to CXMT, which listed on the Shanghai Stock Exchange on 27 July 2026. CMS holds 505mn CXMT shares, or 0.74% of shares outstanding. Based on the 18 September closing price, the institution estimates a Rmb27bn unrealized gain, equivalent to roughly 2.2 times CMS's FY25 net profit. Because the holding remains locked up, CMS must apply a liquidity discount when recognizing gains, but J.P. Morgan estimates a Rmb13.5bn potential 3Q profit-and-loss impact from CXMT after a 50% adjustment factor. Its table of key investments shows aggregate potential 3Q P&L impact of Rmb12.2bn after including a Rmb1.3bn negative contribution from Dapustor. The report identifies 3Q26 earnings as the key near-term catalyst. On the current quarter-to-date run rate, J.P. Morgan forecasts CMS net profit of Rmb10.681bn in 3Q26, up 45% quarter on quarter and 190% year on year. Investment gains are forecast to rise to Rmb16.734bn, up 59% quarter on quarter and 364% year on year, driving total revenue and other income to Rmb20.439bn, up 165% year on year. This is contrasted with difficult sector conditions: average daily trading turnover and margin-financing balances are estimated to be down 19% and 13% quarter on quarter, respectively. The report expects CMS's company-specific investment gains to support substantial relative earnings outperformance despite softer sector trading activity. J.P. Morgan believes the market has not fully reflected the CXMT value. Since 18 May, after CXMT disclosed 1Q26 operating data, CMS-A and CMS-H rose 9% and 6%, outperforming A-share and H-share broker peers by 7 percentage points and 3 percentage points. However, relative outperformance had narrowed from 22 percentage points and 23 percentage points in early July as technology sentiment cooled; CMS A/H were each down 19% from 3 July to the report date, versus declines of 12% for A-share broker peers and 6% for H-share peers. The institution estimates that CMS-A reflects only around 35%-40% of the CXMT-related gain and CMS-H around 10%. It also notes that the STAR50 Index had stabilized and rebounded over the preceding week, which it interprets as improving technology-stock sentiment. The model update incorporates 2Q26 results. J.P. Morgan cuts commission-fee-income assumptions because of declining trading turnover and continuing fee-rate pressure, but says stronger CXMT-related investment income more than offsets this. It raises 2026E net profit by 15.8%, while trimming 2027E and 2028E net profit by 2.4% and 2.7%. For FY26E, it forecasts net revenue of Rmb54.500bn, adjusted net income of Rmb21.815bn, adjusted EPS of Rmb2.51, a 40.0% net margin, and adjusted EPS growth of 85.6%; FY27E adjusted EPS is forecast to fall 23.0% to Rmb1.93 as the exceptional investment-income effect moderates. J.P. Morgan reiterates Overweight on both lines and raises the Jun-27 target price to Rmb23.50 for CMS-A from Rmb23.00 and to HK$21.00 for CMS-H from HK$20.50. The A-share target implies 33% upside from Rmb17.59 as of 18 September, while the H-share target implies 43% upside from HK$14.82. The A-share valuation combines a dividend discount model for FY26E-FY28E dividends with a terminal value based on an ROE-growth versus cost-of-equity-growth approach. The current fair value is Rmb16.8 and the Jun-27 fair value is Rmb18.3, to which J.P. Morgan applies a 129% A/H adjustment based on the prior one-year moving-average premium. Key assumptions are a 1.8% risk-free rate, 8.0% equity risk premium, 1.2x beta, 11.4% cost of capital and 4.5% long-term growth rate. The H-share target converts the Rmb fair value using spot CNY/HKD.

Analysis framework

J.P. Morgan first estimates CMS's CXMT holding, market value and unrealized gains, then applies a liquidity adjustment to estimate the earnings impact while the shares remain locked up. It compares CMS's share-price performance with broker peers, forecasts 3Q26 earnings by revenue line, updates multi-year estimates after 2Q26 results, and values the shares using a dividend discount model with a terminal-value framework.

Methodology notes

• Valuation methodsDDM (Dividend Discount Model)

  Dividend discount model with a terminal value based on ROE-growth and cost-of-equity-growth assumptions.

  The report discounts FY26E-FY28E dividends and terminal value to derive a current and Jun-27 fair value for CMS, then adjusts the A-share valuation for the historical A/H premium and converts the H-share target using spot CNY/HKD.

• Industry AnalysisVolume-price decomposition

  Assessment of brokerage fee income through trading turnover, margin-financing balances and fee-rate trends.

  J.P. Morgan lowers commission-fee assumptions because sector trading activity and margin financing are weakening and fee rates remain under pressure, then compares this drag with the stronger investment-income contribution from CXMT.

Asset mapping & comparison

Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).

• China Merchants Securities Company Ltd - A (600999.SS)

  Primary covered A-share; expected to benefit from CXMT-related investment income in 3Q26.

  Strengths

  Highest CXMT exposure among China brokers; reported brokerage market-share gains and expected mutual-fund-business growth.

  Weaknesses

  Commission fee income assumptions were reduced for weaker trading turnover and fee-rate pressure.

  Comparison

  Since 18 May, it outperformed A-share broker peers by 7 percentage points, down from 22 percentage points in early July.

  Risks

  Government stabilization-fund contributions, hedging restrictions, tighter asset-management regulation and long-term commission-rate pressure.

• China Merchants Securities Company Ltd - H (6099.HK)

  Primary covered H-share; shares the same CXMT-driven earnings exposure as CMS-A.

  Strengths

  High CXMT exposure and expected investment-income uplift in 3Q26.

  Weaknesses

  The H-share has underperformed its early-July relative-performance peak amid weaker technology sentiment.

  Comparison

  Since 18 May, it outperformed H-share broker peers by 3 percentage points, down from 23 percentage points in early July.

  Risks

  Government stabilization-fund contributions, hedging restrictions, tighter asset-management regulation and long-term commission-rate pressure.

Key data

• CMS CXMT holding505mn shares, 0.74% of CXMT shares outstandingEstimated to generate around Rmb27bn of unrealized gains.
• Estimated CXMT unrealized gainRmb27bnEquivalent to about 2.2x CMS FY25 net profit.
• 3Q26E net profitRmb10.681bnForecast to rise 45% quarter on quarter and 190% year on year.
• 3Q26E investment gainsRmb16.734bnForecast to increase 59% quarter on quarter and 364% year on year.
• FY26E adjusted EPSRmb2.51Raised 15.8%; adjusted EPS growth forecast at 85.6% year on year.
• Jun-27 price targetsRmb23.50 for CMS-A; HK$21.00 for CMS-HImply 33% and 43% potential upside, respectively.

Impact & implications

The report expects CMS's CXMT investment gain to differentiate its 3Q26 earnings from a broker sector facing weaker trading turnover and margin-financing trends. J.P. Morgan believes the earnings catalyst and incomplete pricing of the gain could support renewed relative performance for both share classes.

Risks

• Required contributions to the government stabilization fund and restrictions on hedging could weigh on results.
• Tighter regulation of rapidly expanding domestic asset-management businesses could affect the business.
• Online and mobile platforms, fragmented market conditions and possible brokerage-fee deregulation could sustain pressure on commission rates.

What to watch

• CMS's 3Q26 results and the extent to which CXMT-related gains are recognized after liquidity discounts.
• Trading turnover and margin-financing balances, which J.P. Morgan expects to remain weak for the broker sector in 3Q.
• Technology-sector sentiment and CXMT share-price stability following its July 2026 listing.
• Brokerage commission trends, fee-rate pressure and CMS's market-share progress.